The effects of medical ozone therapy on renal ischemia/reperfusion injury

Renal Failure

Volumn 34, Issue 7, 2012, Pages 921-925

  Oztosun, Muzaffer ^a   Akgul, Emin Ozgur ^b   Cakir, Erdinc ^b   Cayci, Tuncer ^b   Uysal, Bulent ^b   Ogur, Recai ^b   Ozcan, Ayhan ^b   Ozgurtas, Taner ^b   Guven, Ahmet ^b   Korkmaz, Ahmet ^b  

^a Turkish Armed Forces   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

ischemia reperfusion; neopterin; oxidative stress; ozone therapy; renal

Indexed keywords

GLUTATHIONE PEROXIDASE; LIPID; NEOPTERIN; NITRITE; PROTEIN; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOCHEMISTRY; CONTROLLED STUDY; EVALUATION; HISTOPATHOLOGY; KIDNEY FUNCTION; KIDNEY ISCHEMIA; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; OZONE THERAPY; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; THERAPY EFFECT;

ACUTE KIDNEY INJURY; ANIMALS; KIDNEY; MALE; OZONE; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

EID: 84863877823     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2012.692752     Document Type: Article

References (38)

1. Sheridan AM, Bonventre JV. Pathophysiology of ischemic acute renal failure. Contrib Nephrol. 2001;132:7-21.
2. Greene EL, Paller MS. Oxygen free radicals in acute renal failure. Miner Electrolyte Metab. 1991;17:124-132.
3. Yaman H, Cayci T, SeyrekM, et al. Effects of vitamin A and C and melatonin on 3-nitrotyrosine formation in guinea pig heart under lipopolysaccharide-induced stress. Turk JMed Sci. 2010;40:715-721.
4. Ersoz N, Guven A, Cayci T, et al. Comparison of the efficacy of melatonin and 1400 W on renal ischemia/reperfusion injury: A role for inhibiting iNOS. Ren Fail. 2009;31:704-710.
5. Guven A, Uysal B, Akgul O, et al. Scavenging of peroxynitrite reduces renal ischemia/reperfusion injury. Ren Fail. 2008;30:747-754.
6. Kizilgun M, Poyrazoglu Y, Oztas Y, et al. Beneficial effects of N-acetylcysteine and ebselen on renal ischemia/reperfusion injury. Ren Fail. 2011;33:512-517.
7. Oztas E, Guven A, Turk E, et al. 3-Aminobenzamide, a poly ADP ribose polymerase inhibitor, attenuates renal ischemia/reperfusion injury. Ren Fail. 2009;31:393-399.
8. Yanarates O, Guven A, Sizlan A, et al. Ameliorative effects of proanthocyanidin on renal ischemia/reperfusion injury. Ren Fail. 2008;30:931-938.
9. Muller MM, Curtius HC, Herold M, et al. Neopterin in clinical practice. Clin Chim Acta. 1991;201:1-16.
10. Ruokonen E, Ilkka L, Niskanen M, et al. Procalcitonin and neopterin as indicators of infection in critically ill patients. Acta Anaesthesiol Scand. 2002;46:398-404. (Pubitemid 34454435)
11. Cayci T, Akgul EO, Kurt YG, et al. Cord blood and maternal serum neopterin concentrations in patients with pre-eclampsia. Clin Chem Lab Med. 2010;48:1127-1131.
12. Gul H, Uysal B, Cakir E, et al. The protective effects of ozone therapy in a rat model of acetaminophen-induced liver injury. Environ Toxicol Pharmacol. 2012;34:81-86.
13. Yaman H, Cakir E, Ozcan O, et al. Elevated urine neopterin levels in nonalcoholic steatohepatitis. Clin Biochem. 2005;38:187-190. (Pubitemid 40092464)
14. Bocci V. Ozone as Janus: This controversial gas can be either toxic or medically useful. Mediators Inflamm. 2004;13:3-11. (Pubitemid 38621643)
15. Bocci VA. Scientific and medical aspects of ozone therapy: State of the art. Arch Med Res. 2006;37:425-435.
16. Oter S, Korkmaz A. Relevance of hyperbaric oxygen to ozone therapy. Arch Med Res. 2006;37:917-918. (Pubitemid 44333154)
17. Re L, Mawsouf MN,Menendez S, et al. Ozone therapy: Clinical and basic evidence of its therapeutic potential. Arch Med Res. 2008;39:17-26. (Pubitemid 350192013)
18. Bocci V. Does ozone therapy normalize the cellular redox balance? Implications for therapy of human immunodeficiency virus infection and several other diseases. Med Hypotheses. 1996;46:150-154. (Pubitemid 26075778)
19. Chatterjee PK, Patel NS, Kvale EO, et al. Inhibition of inducible nitric oxide synthase reduces renal ischemia/reperfusion injury. Kidney Int. 2002;61:862-871. (Pubitemid 34175453)
20. Altinel O, Demirbas S, Cakir E, et al. Comparison of hyperbaric oxygen and medical ozone therapies in a rat model of experimental distal colitis. Scand J Clin Lab Invest. 2011;71:185-192.
21. Tunc T, Uysal B, Atabek C, et al. Erdosteine and ebselen as useful agents in intestinal ischemia/reperfusion injury. J Surg Res. 2009;155:210-216.
22. Alrashed M, AbougoushM, Akgul E, et al. Detection method of serumand urine neopterin levels by high performance liquid chromatography and clinical applications. Gulhane MJ. 2002;44:273-277.
23. Cakir E, Akgul OE, Aydin I, et al. The association between neopterin and acetaminophen-induced nephrotoxicity. Ren Fail. 2010;32:740-746.
24. Rabb H, Ramirez G, Saba SR, et al. Renal ischemic-reperfusion injury in L-selectin-deficient mice. Am J Physiol. 1996;271:F408-F413.
25. Halliwell B, Clement MV, Long LH. Hydrogen peroxide in the human body. FEBS Lett. 2000;486:10-13.
26. Zamora ZB, Borrego A, Lopez OY, et al. Effects of ozone oxidative preconditioning on TNF-alpha release and antioxidant-prooxidant intracellular balance in mice during endotoxic shock. Mediators Inflamm. 2005;1:16-22. (Pubitemid 40942906)
27. Reth M. Hydrogen peroxide as second messenger in lymphocyte activation. Nat Immunol. 2002;3:1129-1134. (Pubitemid 35469696)
28. Ajamieh H, Merino N, Candelario-Jalil E, et al. Similar protective effect of ischemic and ozone oxidative preconditionings in liver ischemia/reperfusion injury. Pharmacol Res. 2002;45:333-339. (Pubitemid 35430529)
29. Chen H, Xing B, Liu X, et al. Similarities between ozone oxidative preconditioning and ischemic preconditioning in renal ischemia/reperfusion injury. Arch Med Res. 2008;39:169-178. (Pubitemid 350299621)
30. Madej P, Plewka A, Madej JA, et al. Ozonotherapy in an induced septic shock I: Effect of ozonotherapy on rat organs in evaluation of free radical reactions and selected enzymatic systems. Inflammation. 2007;30:52-58. (Pubitemid 46438048)
31. Bocci V, Zanardi I, Travagli V. Has oxygen-ozonetherapy a future in medicine? J Exp Integr Med. 2011;1:5-11.
32. Fuchs D, Weiss G, Wachter H. Neopterin, biochemistry and clinical use as a marker for cellular immune reactions. Int Arch Allergy Immunol. 1993;101:1-6. (Pubitemid 23179069)
33. Bocci V, Borrelli E, Travagli V, et al. The ozone paradox: Ozone is a strong oxidant as well as a medical drug. Med Res Rev. 2009;29:646-682.
34. Caliskan B,GuvenA,OzlerM, et al.Ozone therapy prevents renal inflammation and fibrosis in a rat model of acute pyelonephritis. Scand J Clin Lab Invest. 2011;71:473-480.
35. Demirbag S, Uysal B, Guven A, et al. Effects of medical ozone therapy on acetaminophen-induced nephrotoxicity in rats. Ren Fail. 2010;32:493-497.
36. Guven A, Gundogdu G, Sadir S, et al. The efficacy of ozone therapy in experimental caustic esophageal burn. J Pediatr Surg. 2008;43:1679-1684.
37. Guven A, Gundogdu G, Vurucu S, et al. Medical ozone therapy reduces oxidative stress and intestinal damage in an experimental model of necrotizing enterocolitis in neonatal rats. J Pediatr Surg. 2009;44:1730-1735.
38. Uysal B, Yasar M, Ersoz N, et al. Efficacy of hyperbaric oxygen therapy and medical ozone therapy in experimental acute necrotizing pancreatitis. Pancreas. 2010;39:9-15.